What You Should Know:
- Pear Therapeutics today announced that it has
successfully closed an $80 million Series D financing led by SoftBank Vision
Fund 2.
- Pear is the
leader in prescription digital therapeutics and the first company to receive
FDA authorization for a prescription digital therapeutic (PDT) to treat
disease.
- Pear currently has three FDA authorized therapies, reSET, reSET-O and Somryst, for substance use disorder, opioid use disorder, and chronic insomnia,
Read More
Digital Therapeutics | Digital Health | Evidence-Based Therapeutics Interventions
Brigham, Biofourmis Co-Develops Tech Solution to Enable Home Hospital Care
What You Should Know:
- Brigham is working with Biofourmis on a national
rollout of their co-developed technology solution, which has been refined and
scaled for use by other healthcare systems across the country seeking to
establish and execute similar home hospital programs to alleviate COVID-related
capacity issues and to receive 1:1 parity on payments from CMS.
- The Hospital@HomeTM platform provides a turnkey,
end-to-end ecosystem for any health system that wants to quickly launch
Read More
UCB Taps Medisafe to Develop Branded Digital Drug Companions for Antiepileptic Medications
What You Should Know:
- UCB has selected Medisafe to develop branded digital
drug companions for antiepileptic medications, marking the company’s official
entry into the digital therapeutics space.
- The initial collaboration will primarily be focused on their antiepileptic medications, but they are exploring its use for additional brands.
Medisafe,
a leading digital
therapeutics company specializing in digital companions, has been selected
by UCB to develop branded digital
Read More
DarioHealth Selected as Digital Chronic Care Solution by Self Insured, Fortune 500 Company
What You Should Know:
- DarioHealth Corp., a pioneer in the global digital therapeutics market, announced today that it has signed a contract to provide its digital therapeutics solution to eligible employees of a U.S.-based Fortune 500 technology company.
- Dario's top-rated digital diabetes tools and coaching will
be available to eligible employees and their dependents starting January 1,
2021
- Dario helps manage and improve the health of people living
with chronic conditions such
Read More
Aptar Pharma Acquires the Assets of Respiratory Startup Cohero Health
What You Should Know:
- Apstar Pharma acquires the assets of respiratory health company Cohero Health to expands its digital portfolio with a focus on respiratory disease management.
- Cohero Health develops digital tools and technologies to improve respiratory care, reduce avoidable costs, and optimize medication utilization.
AptarGroup, Inc., a global leader in consumer dispensing, active packaging, drug delivery solutions, and services, announces that it has acquired all operating
Read More
Redox Integrates Voluntis’ Digital Therapeutics Within EHR
What You Should Know:
- Voluntis forms a strategic partnership with Redox to integrate Voluntis' digital therapeutics within existing clinical workflows and EHRs.
- Integration of Voluntis’ Theraxium platform with the
Redox Engine used by more than 900 healthcare organizations using 55 EHRs
across the country.
- The first area of this application will be in oncology,
with future extensions in other therapeutic areas. As a result, clinical staff
will be better equipped to serve each
Read More
FDA Grants AppliedVR Breakthrough Designation for Virtual Reality Chronic Pain Treatment
What You Should Know:
- FDA awards AppliedVR Breakthrough Device designation for
treating treatment-resistant fibromyalgia and chronic intractable lower back
pain
- AppliedVR’s EaseVRx program helps patients learn self-management skills grounded in evidence-based cognitive-behavioral therapy (CBT) principles and other behavioral methods.
AppliedVR,
a pioneer advancing the next generation of digital medicine, today announced
its EaseVRx product received Breakthrough Device designation
Read More
Consumers Cite Trump as Leading Driver of COVID-19 Vaccine Skepticism
What You Should Know:
- 65% of patients say they will wait to receive the
forthcoming COVID-19 vaccine even if it becomes available before the end,
according to a new Medisafe survey.
- Consumers cited greater trust in Dr. Anthony Fauci and established protocols as a leading factor in determining whether to take the vaccine, and listed President Trump as the leading detractor in driving COVID-19 vaccine skepticism and hesitancy in its effectiveness.
Real-world results show users
Read More
PreferredOne Becomes First Health Plan to Cover Prescription Digital Therapeutics
What You Should Know:
- PreferredOne teams with Pear to provide its members
with covered access to two prescription digital therapeutics (PDTs) for the
treatment of substance use disorder (SUD) and opioid use disorder (OUD)
- PDTs are a new therapeutic class that uses software to
directly treat disease. Like traditional medicines, PDTs are tested in
randomized controlled trials demonstrating safety and effectiveness, evaluated
and authorized by regulators like FDA, and used under the
Read More
Medisafe Launches New Platform for Medication Management to Improve Patient Journey
What You Should Know:
- Medisafe launches a new Medisafe Maestro platform that brings precision and speed to patient journeys.
- The new platform aims to revolutionize digital health platforms by combining a host of resources to help patients through any hurdle in their journey and updates and monitoring happen in real-time to meet patients in their moments.
Medisafe, a Boston,
MA-based digital therapeutics companion platform, announced the immediate
deployment of its new Medisafe
Read More
